Laxatives are among the most commonly used drugs or additives. Most are qui
te safe when used judiciously, intermittently when possible, and in the abs
ence of contraindications. Bulking agents and nonabsorbable compounds such
as lactulose can cause bloating but have very few serious adverse effects e
xcept for the allergic reaction to psyllium preparations. Osmotic laxatives
containing poorly absorbable ions such as magnesium or phosphate can cause
metabolic disturbances, particularly in the presence of renal impairment.
However, if taken intermittently, in the absence of conditions such as ileu
s or bowel obstruction, they have few adverse effects. Polyethylene glycol
solutions are emerging as an effective and safe mode of treatment for chron
ic constipation. Of stimulant laxatives, senna compounds and bisacodyl are
the most commonly used. Although there are data to support the neoplastic p
otential of this class of drugs in in vitro studies, epidemiologic data in
humans so far has not established a clear link between these laxatives and
colonic neoplasia. The link between stimulant laxatives and structural chan
ges, such as the "cathartic colon" or enteric nerve damage, is not well est
ablished either. Danthron compounds should be avoided because of hepatotoxi
city.